Acromegaly Therapy
Research from Pfizer Pharma GmbH has provided new data on acromegaly therapy
Published in Healthcare Mergers, Acquisitions and Ventures Week, March 24th, 2007
New research, "Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study," is the subject of a report. According to recent research from Karlsruhe, Germany, "The GH receptor antagonist pegvisomant is a highly effective new treatment option in acromegaly. The German Pegvisomant Observational Study (GPOS) was started to monitor long-term safety and efficacy of pegvisomant as prescribed in clinical practice."
"GPOS is an observational, multi-center, surveillance study, which comprises non-interventional data collection. Of the 229 patients included in the study,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Abdominal Aortic Aneurysm
Abdominal Aortic Aneurysm Stent Graft Market to Grow to $550 Million by 2011 - Acne Vulgaris
CollaGenex Pharmaceuticals Announces Positive Results of Phase 2 Dose-Finding Study of Incyclinide for the Treatment of Acne - Acusphere
Acusphere Announces Key Promotions in Research and Development - Adaptis
Adaptis to Offer Subrogation Services Through SOCRATES INC. - ADVENTRX Pharmaceuticals, Inc.
ADVENTRX Announces M. Ross Johnson to Retire as Board Chairman - Agency for Healthcare Research and Quality
AHRQ and Ad Council Encourage Patients to Ask Questions and Get More Involved With Their Health Care - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
